Literature DB >> 27601951

Dosimetric analysis of Co-60 source based high dose rate (HDR) brachytherapy: A case series of ten patients with carcinoma of the uterine cervix.

Om Prakash Gurjar1, Manika Batra1, Priyusha Bagdare1, Sandeep Kaushik2, Atul Tyagi2, Ayush Naik1, Virendra Bhandari1, Krishna Lal Gupta1.   

Abstract

AIM: To analyse the dosimetric parameters of Co-60 based high dose rate (HDR) brachytherapy plans for patients of carcinoma uterine cervix.
BACKGROUND: Co-60 high dose rate (HDR) brachytherapy unit has been introduced in past few years and is gaining importance owing to its long half life, economical benefits and comparable clinical outcome compared to Ir-192 HDR brachytherapy.
MATERIALS AND METHODS: A study was conducted on ten patients with locally advanced carcinoma of the uterine cervix (Ca Cx). Computed tomography (CT) images were taken after three channel applicator insertions. The planning for 7 Gray per fraction (7 Gy/#) was done for Co-60 HDR brachytherapy unit following the American Brachytherapy Society (ABS) guidelines. All the patients were treated with 3# with one week interval between fractions.
RESULTS: The mean dose to high risk clinical target volumes (HRCTV) for D90 (dose to 90% volume) was found to be 102.05% (Standard Deviation (SD): 3.07). The mean D2cc (dose to 2 cubic centimeter volume) of the bladder, rectum and sigmoid were found to be 15.9 Gy (SD: 0.58), 11.5 Gy (SD: 0.91) and 4.1 Gy (SD: 1.52), respectively.
CONCLUSION: The target coverage and doses to organs at risk (OARs) were achieved as per the ABS guidelines. Hence, it can be concluded that the Co-60 HDR brachytherapy unit is a good choice especially for the centers with a small number of brachytherapy procedures as no frequent source replacement is required like in an Ir-192 HDR unit.

Entities:  

Keywords:  Co-60 HDR brachytherapy unit; HDR Plus treatment planning system; High risk clinical target volumes

Year:  2016        PMID: 27601951      PMCID: PMC5002016          DOI: 10.1016/j.rpor.2016.01.003

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  13 in total

1.  Treatment planning for high dose rate brachytherapy of cervical cancer based on total dose constraints.

Authors:  Yasir A Bahadur; Camelia T Constantinescu; Ashraf H Hassouna; Mohamed E El-Sayed
Journal:  Saudi Med J       Date:  2011-05       Impact factor: 1.484

2.  Experimental and Monte Carlo study of the effect of the presence of dry air, cortical bone inhomogeneities and source position on dose distribution of the mHDR-v2 source.

Authors:  Rakesh M Chandola; Samit Tiwari; Manjula Beck; Pradeep Kumar Chandrakar; Suresh Kumar Thakur
Journal:  J Cancer Res Ther       Date:  2012 Oct-Dec       Impact factor: 1.805

3.  Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy.

Authors:  Petra Georg; Stefan Lang; Johannes C A Dimopoulos; Wolfgang Dörr; Alina E Sturdza; Daniel Berger; Dietmar Georg; Christian Kirisits; Richard Pötter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-10       Impact factor: 7.038

4.  Measurement and calculation of the dose at large distances from brachytherapy sources: Cs-137, Ir-192, and Co-60.

Authors:  J L Venselaar; P H van der Giessen; W J Dries
Journal:  Med Phys       Date:  1996-04       Impact factor: 4.071

Review 5.  Human papillomavirus and cervical cancer.

Authors:  Mark Schiffman; Philip E Castle; Jose Jeronimo; Ana C Rodriguez; Sholom Wacholder
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

6.  Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.

Authors:  Johannes C A Dimopoulos; Stefan Lang; Christian Kirisits; Elena F Fidarova; Daniel Berger; Petra Georg; Wolfgang Dörr; Richard Pötter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-14       Impact factor: 7.038

7.  A dosimetric analysis of 6 MV versus 15 MV photon energy plans for intensity modulated radiation therapy (IMRT) of carcinoma of cervix.

Authors:  Atul Tyagi; Sanjay S Supe; Man P Singh
Journal:  Rep Pract Oncol Radiother       Date:  2010-09-22

Review 8.  Brachytherapy in the treatment of cervical cancer: a review.

Authors:  Robyn Banerjee; Mitchell Kamrava
Journal:  Int J Womens Health       Date:  2014-05-28

9.  Treatment planning study of the 3D dosimetric differences between Co-60 and Ir-192 sources in high dose rate (HDR) brachytherapy for cervix cancer.

Authors:  Antony Palmer; Orla Hayman; Sarah Muscat
Journal:  J Contemp Brachytherapy       Date:  2012-03-30

10.  Comparison of (60)Co and (192)Ir sources in HDR brachytherapy.

Authors:  Stefan Strohmaier; Grzegorz Zwierzchowski
Journal:  J Contemp Brachytherapy       Date:  2011-12-30
View more
  2 in total

1.  The Design of an Audit Test for 60Co Brachytherapy Treatment Planning System.

Authors:  Mohammad Javad Tahmasebi Birgani; Hadis Khorshidsavar; Ali Bagheri; Amir Danyaei; Neda Abdalvand
Journal:  J Med Signals Sens       Date:  2022-05-12

Review 2.  Comparative Analysis of 60Co and 192Ir Sources in High Dose Rate Brachytherapy for Cervical Cancer.

Authors:  Aiping Wen; Xianliang Wang; Bingjie Wang; Chuanjun Yan; Jingyue Luo; Pei Wang; Jie Li
Journal:  Cancers (Basel)       Date:  2022-09-29       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.